NUONCOLOGY LABS, INC. Inactive Instrument
NuOncology Labs, Inc. Share Price Other OTC
Equities
NLAB
US67057T1079
Construction & Engineering
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2021 | - | Sales 2022 | - | Capitalization | 16Cr 1.3TCr |
|---|---|---|---|---|---|
| Net income 2021 | - 0 | Net income 2022 | - 0 | EV / Sales 2021 * | - |
| Net cash position 2021 * | - 0 | Net Debt 2022 | 41.88T 34.97L | EV / Sales 2022 | - |
| P/E ratio 2021 * |
-
| P/E ratio 2022 |
-2,229
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Yan-Ping Sheng
CEO | Chief Executive Officer | 63 | - |
Sunny Sukardi
CHM | Chairman | 59 | 31/23/31 |
Taihe Group, Inc. is engaged in the business of development and construction of land and properties relating to tourism, integrating real estate and villas, as well as hospitality services and cargo freight logistics services. The Company has no revenue from operations.
Sector
Construction & Engineering
| 1st Jan change | Capi. | |
|---|---|---|
| +1.85% | 7.13TCr | |
| -5.03% | 5.42TCr | |
| +23.00% | 3.89TCr | |
| +15.38% | 3.19TCr | |
| +8.96% | 2.77TCr | |
| +19.89% | 2.17TCr | |
| +17.68% | 1.99TCr | |
| +73.40% | 1.76TCr | |
| +35.63% | 1.8TCr |
